Howell-Jolly body-like inclusions in immunocompromised patients with antiviral treatment.
Servicio de Hematología, Laboratori de Referència de Catalunya, El Prat de Llobregat, Barcelona, Spain, cmorales.germanstrias@gencat.cat.
Cristian
C
Morales-Indiano
Leonor
L
Arenillas Rocha
Virginia
V
Mas Bosch
Lourdes
L
Florensa Brichs
D000212:Acyclovir / Q000494:pharmacology* / Q000627:therapeutic use; D000368:Aged; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016477:Artifacts; D002467:Cell Nucleus / Q000187:drug effects* / Q000648:ultrastructure; D003937:Diagnosis, Differential; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D002479:Inclusion Bodies / Q000648:ultrastructure*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects / Q000648:ultrastructure*; D012394:Rosaniline Dyes; D000077562:Valganciclovir
D000998:Antiviral Agents; C007722:Feulgen stain; D012394:Rosaniline Dyes; D000077562:Valganciclovir; D015774:Ganciclovir; D000212:Acyclovir